These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 17100716)

  • 41. Do implantable cardioverter defibrillators lower mortality risk in patients with cardiomyopathy?
    Gersh B
    Nat Clin Pract Cardiovasc Med; 2004 Nov; 1(1):16-7. PubMed ID: 16265252
    [No Abstract]   [Full Text] [Related]  

  • 42. Prevention of sudden cardiac death: rationale and design of the Implantable Cardioverter Defibrillators in Dialysis patients (ICD2) Trial--a prospective pilot study.
    de Bie MK; Lekkerkerker JC; van Dam B; Gaasbeek A; van Buren M; Putter H; van Erven L; Bax JJ; Schalij MJ; Rabelink TJ; Jukema JW
    Curr Med Res Opin; 2008 Aug; 24(8):2151-7. PubMed ID: 18561878
    [TBL] [Abstract][Full Text] [Related]  

  • 43. AICD treatment in 2004--state of the art.
    Budde T
    Eur J Med Res; 2006 Oct; 11(10):432-8. PubMed ID: 17107877
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Implantable cardioverter-defibrillators in patients with left ventricular noncompaction.
    Kobza R; Jenni R; Erne P; Oechslin E; Duru F
    Pacing Clin Electrophysiol; 2008 Apr; 31(4):461-7. PubMed ID: 18373765
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Use of beta-blockers in patients with an implantable cardioverter defibrillator.
    LaPointe NM; Stafford JA; Pappas PA; Al-Khatib SM; Anstrom KJ
    Ann Pharmacother; 2009 Jul; 43(7):1189-96. PubMed ID: 19567655
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Sudden cardiac death of two heart transplant patients with correctly functioning implantable cardioverter defibrillators.
    Marzoa-Rivas R; Perez-Alvarez L; Paniagua-Martin MJ; Ricoy-Martinez E; Flores-Ríos X; Rodriguez-Fernandez JA; Salgado-Fernandez J; Franco-Gutierrez R; Cuenca-Castillo JJ; Herrera JM; Capdevila A; Vazquez P; Castro-Beiras A; Crespo-Leiro MG
    J Heart Lung Transplant; 2009 Apr; 28(4):412-4. PubMed ID: 19332273
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Long-term survival of patients with heart failure and ventricular conduction delay treated with cardiac resynchronization therapy.
    Auricchio A; Metra M; Gasparini M; Lamp B; Klersy C; Curnis A; Fantoni C; Gronda E; Vogt J;
    Am J Cardiol; 2007 Jan; 99(2):232-8. PubMed ID: 17223424
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Statin use was associated with reduced mortality in both ischemic and nonischemic cardiomyopathy and in patients with implantable defibrillators: mortality data and mechanistic insights from the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT).
    Dickinson MG; Ip JH; Olshansky B; Hellkamp AS; Anderson J; Poole JE; Mark DB; Lee KL; Bardy GH;
    Am Heart J; 2007 Apr; 153(4):573-8. PubMed ID: 17383296
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Inappropriate implantable cardioverter-defibrillator shocks in MADIT II: frequency, mechanisms, predictors, and survival impact.
    Daubert JP; Zareba W; Cannom DS; McNitt S; Rosero SZ; Wang P; Schuger C; Steinberg JS; Higgins SL; Wilber DJ; Klein H; Andrews ML; Hall WJ; Moss AJ;
    J Am Coll Cardiol; 2008 Apr; 51(14):1357-65. PubMed ID: 18387436
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Risk factors for sudden cardiac death in patients with chronic renal insufficiency and left ventricular dysfunction.
    Chonchol M; Goldenberg I; Moss AJ; McNitt S; Cheung AK
    Am J Nephrol; 2007; 27(1):7-14. PubMed ID: 17204832
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Implications of cardiac resynchronization therapy and prophylactic defibrillator implantation among patients eligible for heart transplantation.
    Pedone C; Grigioni F; Boriani G; Lofiego C; Vassallo PL; Potena L; Coccolo F; Magnani G; Biffi M; Martignani C; Frabetti L; Zannoli R; Magelli C; Branzi A
    Am J Cardiol; 2004 Feb; 93(3):371-3. PubMed ID: 14759396
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Right ventricular pacing is associated with impaired overall survival, but not with an increased incidence of ventricular tachyarrhythmias in routine cardioverter/defibrillator recipients with reservedly programmed pacing.
    Stockburger M; Celebi O; Krebs A; Knaus T; Nitardy A; Habedank D; Dietz R
    Europace; 2009 Jul; 11(7):924-30. PubMed ID: 19447808
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Causes of redo procedures in patients with an implantable cardioverter-defibrillator--long-term follow-up results.
    Gepner K; Przybylski A; Maciag A; Sterliński M; Lewandowski M; Syska P; Kowalik I; Szwed H
    Kardiol Pol; 2007 Aug; 65(8):893-8; discussion 899. PubMed ID: 17853318
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Implantable cardioverter defibrillator therapy for primary prevention of sudden cardiac death after myocardial infarction: implications of international guidelines.
    Foley PW; Addison CE; Whinney SB; Patel K; Cunningham D; Frenneaux MP; Leyva F
    Pacing Clin Electrophysiol; 2009 Mar; 32 Suppl 1():S131-4. PubMed ID: 19250076
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Incidence, predictors, and temporal trends of sudden cardiac death after heart transplantation.
    Vakil K; Taimeh Z; Sharma A; Abidi KS; Colvin M; Luepker R; Levy WC; Adabag S
    Heart Rhythm; 2014 Oct; 11(10):1684-90. PubMed ID: 25048441
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Inverse relationship of blood pressure levels to sudden cardiac mortality and benefit of the implantable cardioverter-defibrillator in patients with ischemic left ventricular dysfunction.
    Goldenberg I; Moss AJ; McNitt S; Zareba W; Hall WJ; Andrews ML;
    J Am Coll Cardiol; 2007 Apr; 49(13):1427-33. PubMed ID: 17397670
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Benefit of primary prevention implantable cardioverter-defibrillators in the setting of chronic kidney disease: a decision model analysis.
    Amin MS; Fox AD; Kalahasty G; Shepard RK; Wood MA; Ellenbogen KA
    J Cardiovasc Electrophysiol; 2008 Dec; 19(12):1275-80. PubMed ID: 18662180
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Primary prevention of sudden cardiac death using implantable cardioverter defibrillators.
    Ding L; Hua W; Niu H; Chen K; Zhang S
    Europace; 2008 Sep; 10(9):1034-41. PubMed ID: 18559335
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Indications for ICD and cardiac resynchronization therapy for prevention of sudden cardiac death.
    Das M
    Expert Rev Cardiovasc Ther; 2009 Feb; 7(2):181-95. PubMed ID: 19210214
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Implantable defibrillators and prevention of sudden death in hypertrophic cardiomyopathy.
    Maron BJ; Spirito P
    J Cardiovasc Electrophysiol; 2008 Oct; 19(10):1118-26. PubMed ID: 18384577
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.